Tarchomin Pharmaceutical Works "Polfa" S.A.

Acronym: TZF

General Information

Identification Code: 316556891811-84

Website: https://www.polfa-tarchomin.com.pl

Entity Form: S.A. (plc)

Registration Category: Companies & groups

Registration Date: 4/19/2024

Mission & Interests

Goals: Polish generic pharmaceutical company, producer of APIs and FDFs critical for European and international markets. Company with 200 years of history in pharma business. The only polish penicillin's manufacturer, a strong player in antibiotics market, producer of human insulin, highly experienced in sterile production. We heavily invest in new state of the art production facility dedicated to hilgly potent drugs.

Interests Represented: Promotes their own interests or the collective interests of their members

Interests:

Budget
Climate action
Public health
Research and innovation

Levels of Interest:

national
european
global
sub-national

Activities

Main EU Legislative Proposals: EMA/528805/2023 Union list of critical medicines - version 1 Vulnerabilities in critical medicines supply chains

Communication Activities: https://www.ema.europa.eu/en/news/first-version-union-list-critical-medicines-agreed-help-avoid-potential-shortages-eu https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera_en https://health.ec.europa.eu/health-emergency-preparedness-and-response-hera/overview/critical-medicines-alliance_en https://www.edqm.eu/en/groups-of-experts-and-working-parties

Inter-institutional or Unofficial Groupings: N/A

Head Office

Address: Fleminga 2

Post Code: 03-176

City: Warszawa

Country: POLAND

Phone:

Indic Phone: 48

Phone Number: (22) 510 80 01

EU Office

Address: Fleminga 2

Post Code: 03-176

City: Warszawa

Country: POLAND

Phone:

Indic Phone: 00881

Phone Number: 453 018 392

Financial Data

Closed Year:

Start Date:

End Date:

Funding Sources:

Contributions:

Total Budget: 0

Grants:

Current Year:

Grants:

Membership Information

Members10 Percent: 4

Members: 4

Members F T E: 0.4000000059604645

Info Members: 4 people work in close cooperation with HEAR at data collection survey for the pilot phase of the critical medicines vulnerability analysis to collect necessary data and work as EDQM experts in working groups. Their percentage involvement regarding to full time job is estimated for 10%.

Structure

Structure Type: Structure

Is Member Of: Małgorzata Stokrocka - Expert in EDQM Working Group Rafał Łunio - Expert in EDQM Working Group Monika Janicka - Expert in EDQM Working Group

Organisation Members: EDQM